Cardiovascular benefits of semaglutide: a systematic review and meta-analysis of randomized controlled trials [0.03%]
司美格鲁肽心血管获益的系统评价和meta分析
Samin Sadraei,Aryan Aarabi,Shahryar Rajai Firouzabadi et al.
Samin Sadraei et al.
Background: Semaglutide, a GLP-1 receptor agonist (GLP-1RA), has shown potential in controlling type 2 diabetes due to their ability to lower blood glucose and improve cardiovascular outcomes. Although semaglutide is the ...
Association between re-elevation of cardiac biomarkers and in-hospital MACE after primary PCI in STEMI patients [0.03%]
急性心肌梗死患者行直接PCI术后心脏生物标志物再次升高与院内主要心血管事件的关系
Xiaodou Niu,Yuanji Ma,Xiaotong Cui et al.
Xiaodou Niu et al.
Background: Previous studies have indicated that after reperfusion therapy in patients with myocardial infarction, high-sensitivity cardiac troponin T (hs-cTnT) may exhibit a secondary increase following the initial peak ...
Early initiation of guideline-directed medical therapy in patients with cardiogenic shock supported with Impella®: a two-center retrospective study [0.03%]
早期应用指南指导的药物治疗联合Impella器械治疗心源性休克患者的疗效分析——一项两中心回顾性研究
Junichiro Yokawa,Tetsuo Nishikawa,Masaya Shimojima et al.
Junichiro Yokawa et al.
Background: Determining the optimal timing for initiating guideline-directed medical therapy (GDMT) in survivors of cardiogenic shock remains a clinical challenge. Clinicians must balance the urgency of early intervention...
Multicenter Study
BMC cardiovascular disorders. 2025 Nov 19;25(1):818. DOI:10.1186/s12872-025-05311-5 2025
Comparison of autologous aortic tissue and pericardial patch for neo-pulmonary artery reconstruction during arterial switch operation: a single-surgeon experience [0.03%]
同种主动脉补片与心包补片用于动脉调转术中重建neo-肺动脉的比较：单中心单医师手术报告
Serkan Secici
Serkan Secici
Background: This study aimed to compare the early and mid-term outcomes of neo-pulmonary artery (PA) reconstruction using autologous aortic tissue versus pericardial patch in patients undergoing arterial switch operation ...
Comparative Study
BMC cardiovascular disorders. 2025 Nov 19;25(1):819. DOI:10.1186/s12872-025-05321-3 2025
Association of serum uric acid to high-density lipoprotein cholesterol ratio with all-cause mortality and cardiovascular disease mortality in patients with gout [0.03%]
血清尿酸与高密度脂蛋白胆固醇比值与痛风患者全因死亡和心血管疾病死亡相关性研究
Xiaolin Lou,Rubing Guo,Yongtong Cao et al.
Xiaolin Lou et al.
Background: The uric acid to high-density lipoprotein cholesterol ratio (UHR), a novel biomarker, has clinical value in diagnosing and evaluating metabolic syndrome, diabetes mellitus, and atherosclerosis. However, the re...
Ablation versus drug therapy in atrial fibrillation patients with or without prior Pharmacological or direct current cardioversion: results from the CABANA trial [0.03%]
导管消融与药物治疗在既往有或无经药物或电复律成功转复的心房颤动患者中的对比：CABANA试验结果
Wenli Dai,Zejun Yang,Sitong Li et al.
Wenli Dai et al.
Background: Catheter ablation is superior to drug therapy in selected atrial fibrillation (AF) patients, yet the impact of prior non-ablation rhythm control remains unclear. ...
Serum peptidomics profiling reveals fibrinogen alpha chain-derived peptides associated with clinical outcome in patients with heart failure [0.03%]
血清肽组学研究发现与心力衰竭患者临床结局相关的纤维蛋白原α链衍生肽
Kexin Yao,Jingyue Zhao,Jie Yang et al.
Kexin Yao et al.
Background: There is an urgent need for effective risk prediction tools to assess all-cause mortality in heart failure (HF) patients, and recent serum peptidomics advancements may help identify potential biomarkers associ...
Heart failure in Kenya: epidemiology, management patterns, and outcomes from a national multicenter registry [0.03%]
肯尼亚的心力衰竭流行病学、管理方式及结局的全国多中心注册登记研究
Mohamed Hasham Varwani,Nadeem Kassam,Jasmit Shah et al.
Mohamed Hasham Varwani et al.
Introduction: Heart failure (HF) poses a significant and growing public health challenge in Kenya, largely driven by the increasing prevalence of hypertension, diabetes mellitus, and obesity. The condition disproportionat...
Observational Study
BMC cardiovascular disorders. 2025 Nov 14;25(1):814. DOI:10.1186/s12872-025-05158-w 2025
Cardiovascular determinants of the 6-minute walk distance in cardiac transthyretin amyloidosis [0.03%]
心脏转甲状腺素蛋白淀粉样变性患者6分钟步行距离的影响因素
Vladimir Cejka,Clemens Hosp,Maximilian Steinhardt et al.
Vladimir Cejka et al.
Background: The six-minute walk distance (6MWD) is a measure of functional capacity and a frequently used endpoint in clinical trials investigating transthyretin amyloid cardiomyopathy (ATTR-CM). We evaluated the clinical...